$50.220
+0.121 (+0.24%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CRSP Prediction & Forecast by Similar Chart Analysis
Alphio's CRSP stock price prediction model matches the current CRISPR Therapeutics AG tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $49.58 (-1.27%). The 1-week path is $49.58 (-1.27%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy CRISPR Therapeutics AG Stock?
CRISPR Therapeutics AG is currently priced at $53.39, with a forward P/E ratio of 23.36, indicating potential growth but also high valuation. The RSI is at 46.24, suggesting the stock is nearing oversold territory, which could be a buying opportunity. However, insider selling has increased by 476.16%, indicating potential concerns about the company's future performance. Therefore, while there are positive catalysts such as FDA approval for Casgevy and projected revenue growth, the significant insider selling and current financial losses suggest caution. Overall, it may be wise to hold rather than buy at this moment.
CRSP stock price ended at $50.22 on Wednesday, after rising +0.24%
CRISPR Therapeutics AG (CRSP) last closed at $50.22, gaining +0.24%. These facts feed the 1-day and 1-week CRSP price prediction above.
Analyst Consensus
CRISPR Therapeutics AG (CRSP): 3 buy, 3 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
CRISPR Therapeutics AG (CRSP) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CRSP, ranked by similarity.
Seasonality analysis for CRSP
Historically the probability of a positive October return for CRSP is 47.37%. March offers the highest probability of a positive month at 61.90%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CRSP
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $17.82 | $33.96 | $51.74 | -32.38% |
| Nov 2026 | $29.09 | $38.88 | $44.05 | -22.58% |
| Dec 2026 | $37.57 | $46.16 | $57.97 | -8.08% |
In 2026, CRISPR Therapeutics AG (CRSP) is projected to range from $17.82 to $57.97.
CRISPR Therapeutics AG 2026 monthly forecast
In Oct 2026, CRISPR Therapeutics AG is projected to average $33.96, with a low of $17.82 and high of $51.74.
In Nov 2026, CRISPR Therapeutics AG is projected to average $38.88, with a low of $29.09 and high of $44.05.
In Dec 2026, CRISPR Therapeutics AG is projected to average $46.16, with a low of $37.57 and high of $57.97.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.